News | October 07, 2009

GE Healthcare Introduces CARESCAPE Monitor B850

October 7, 2009 – GE Healthcare this week said the FDA cleared the CARESCAPE Monitor B850, which the company said provides caregivers with a new level of integration between patient monitoring data and hospital information systems, because it directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.

This enables CARESCAPE Monitor B850 to integrate its continuous clinical measurements with other elements of the patient record, delivering it at the point of care. GE healthcare said the device brings together the strong clinical heritage of Datex-Ohmeda’s anesthesia and Marquette Electronics’ cardiac expertise. It provides customized clinical information displays by care area and clinician preference, while also enabling hospitals to standardize on a monitoring platform throughout the organization. Developed with thousands of hours of field and in-house testing, the CARESCAPE Monitor B850 is the latest product in the GE Healthcare CARESCAPE portfolio, designed to deliver streamlined access to critical patient information for enhanced decision making.

Traditionally, when a patient experiences chest pain, a caregiver must find and move an ECG machine from a different location to the patient’s bedside. The CARESCAPE Monitor B850 not only enables “cart-less” diagnostic ECGs at the bedside, but also exchanges data with the MUSE ECG repository, facilitating ECG analysis and comparisons to the patient’s prior ECG, supporting more informed clinical decisions.

Anesthesia clinicians have historically administered anesthetics without real-time, integrated anesthetic management tools because anesthesia delivery and patient monitoring systems are often ineffectively integrated. GE Navigator Applications Suite combined with CARESCAPE Monitor B850 analyzes drug therapy information to model and predict the effect of anesthesia-related drugs and drug interactions. This enables clinicians to visualize modeled anesthetic drug effect predictions against live patient data, which supports patient tailored anesthesia.

The CARESCAPE Monitor B850 also enables bedside viewing of hospital EMRs, as well as x-rays, labs and other diagnostic reports, including the associated diagnoses from the hospital’s experts. This quick, comprehensive view of the patient’s records encourages confidence as clinicians make critical decisions at the point of care.

For more information: www.gehealthcare.com

Related Content

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG | January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
AirStrip One, ECG management, web client, U.S. clearance
Technology | ECG | October 11, 2016
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One...
Carestream, Vue Motion universal viewer, ECG waveforms, diagnostic reading, FDA clearance

Image courtesy of Carestream Health

Technology | ECG | November 20, 2015
Carestream has obtained U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of electrocardiogram (...
CardioSecur mobile ECG, 22-lead, 360 degree view of the heart, CardioSecur Pro

Image courtesy of CardioSecur

Technology | ECG | October 08, 2015
Personal MedSystems introduced the first and only 22-lead mobile electrocardiogram (ECG) system, CardioSecur, at the...
Overlay Init